Treatment of viral hepatitis in HIV–coinfected patients–adverse events and their management

This publication has 41 references indexed in Scilit:

• The renal tolerance of low-dose adefovir dipivoxil by lamivudine-resistant individuals co-infected with hepatitis B and HIV
  Nephrology Dialysis Transplantation, 2004
• Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B
  Gastroenterology, 2002
• Human Immunodeficiency Virus (HIV) Type 1 Reverse Transcriptase Resistance Mutations in Hepatitis B Virus (HBV)-HIV-Coinfected Patients Treated for HBV Chronic Infection Once Daily with 10 Milligrams of Adefovir Dipivoxil Combined with Lamivudine
  Antimicrobial Agents and Chemotherapy, 2002
• Safety and efficacy of long-term adefovir dipivoxil (ADV) for lamivudine-resistant (LAM-R) HBV in HIV infected patients
  Journal of Hepatology, 2002
• Fulminant hepatitis B due to a lamivudine-resistant mutant of HBV in a patient coinfected with HIV
  Gastroenterology, 2002
• Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot study
  The Lancet, 2001
• Letters to the Editor
  Journal of Hepatology, 2000
• Acute Exacerbation of Chronic Hepatitis B Virus Infection After Withdrawal of Lamivudine Therapy
  Hepatology, 2000
• Dual Efficacy of Lamivudine Treatment in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Persons in a Randomized, Controlled Study (CAESAR)
  The Journal of Infectious Diseases, 1999
• Interferon alfa treatment of chronic hepatitis B: Randomized trial in a predominantly homosexual male population
  Gastroenterology, 1995